Skip to main content
NCBI home page
Microbiology and Molecular Biology Reviews : MMBR logoLink to Microbiology and Molecular Biology Reviews : MMBR
. 1997 Jun;61(2):170–192. doi: 10.1128/mmbr.61.2.170-192.1997

Macrophages in resistance to candidiasis.

A Vázquez-Torres 1, E Balish 1
PMCID: PMC232606  PMID: 9184009

Abstract

Candida albicans, an increasingly common opportunistic pathogenic fungus, frequently causes disease in immunodeficient but not immunocompetent hosts. Clarifying the role of the phagocytic cells that participate in resistance to candidiasis not only is basic to understanding how the host copes with this dimorphic pathogen but also will expedite the development of innovative prophylactic and therapeutic approaches for treating the multiple clinical presentations that candidiasis encompasses. In this review, we present evidence that a diverse population of mononuclear phagocytes, in different states of activation and differentiation and from a variety of host species, can phagocytize C. albicans blastoconidia via an array of opsonic and nonopsonic mechanisms and can kill C. albicans blastoconidia and hyphae by means of oxygen-dependent and -independent mechanisms. Reactive nitrogen intermediates should now be added to the well-established candidacidal reactive oxygen intermediates of macrophages. Furthermore, what were thought to be two independent pathways, i.e., nitric oxide and superoxide anion, have now been shown to combine to form a potent macrophage candidacidal molecule, peroxynitrite. In contrast to monocytes and neutrophils, which are important in resistance to early stages of C. albicans infections, more differentiated macrophages activated by cytokines such as gamma interferon participate in the acquired resistance of hosts with C. albicans-specific, cell-mediated immunity. Evidence presented in this review demonstrates that mononuclear phagocytes, in some instances in the absence of other professional phagocytes such as neutrophils, play an import role in resistance to systemic and mucosal candidiasis.

Full Text

The Full Text of this article is available as a PDF (299.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel G., Czop J. K. Stimulation of human monocyte beta-glucan receptors by glucan particles induces production of TNF-alpha and IL-1 beta. Int J Immunopharmacol. 1992 Nov;14(8):1363–1373. doi: 10.1016/0192-0561(92)90007-8. [DOI] [PubMed] [Google Scholar]
  2. Allendoerfer R., Magee D. M., Smith J. G., Bonewald L., Graybill J. R. Induction of tumor necrosis factor-alpha in murine Candida albicans infection. J Infect Dis. 1993 May;167(5):1168–1172. doi: 10.1093/infdis/167.5.1168. [DOI] [PubMed] [Google Scholar]
  3. Anderson J. M., Soll D. R. Unique phenotype of opaque cells in the white-opaque transition of Candida albicans. J Bacteriol. 1987 Dec;169(12):5579–5588. doi: 10.1128/jb.169.12.5579-5588.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arai T., Mikami Y., Yokoyama K. Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils. Sabouraudia. 1977 Jul;15(2):171–177. [PubMed] [Google Scholar]
  5. Ashman R. B. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection. Immunol Cell Biol. 1990 Feb;68(Pt 1):15–20. doi: 10.1038/icb.1990.2. [DOI] [PubMed] [Google Scholar]
  6. Ashman R. B., Papadimitriou J. M. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev. 1995 Dec;59(4):646–672. doi: 10.1128/mr.59.4.646-672.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ashman R. B., Papadimitriou J. M. What's new in the mechanisms of host resistance to Candida albicans infection? Pathol Res Pract. 1990 Aug;186(4):527–534. doi: 10.1016/S0344-0338(11)80477-2. [DOI] [PubMed] [Google Scholar]
  8. Baccarini M., Bistoni F., Puccetti P., Garaci E. Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector. Infect Immun. 1983 Oct;42(1):1–9. doi: 10.1128/iai.42.1.1-9.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baccarini M., Kiderlen A. F., Decker T., Lohmann-Matthes M. L. Functional heterogeneity of murine macrophage precursor cells from spleen and bone marrow. Cell Immunol. 1986 Sep;101(2):339–350. doi: 10.1016/0008-8749(86)90147-4. [DOI] [PubMed] [Google Scholar]
  10. Balish E., Balish M. J., Salkowski C. A., Lee K. W., Bartizal K. F. Colonization of congenitally athymic, gnotobiotic mice by Candida albicans. Appl Environ Microbiol. 1984 Apr;47(4):647–652. doi: 10.1128/aem.47.4.647-652.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Balish E., Filutowicz H., Oberley T. D. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect Immun. 1990 Jan;58(1):107–113. doi: 10.1128/iai.58.1.107-113.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bancroft G. J., Schreiber R. D., Unanue E. R. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev. 1991 Dec;124:5–24. doi: 10.1111/j.1600-065x.1991.tb00613.x. [DOI] [PubMed] [Google Scholar]
  13. Beckerman K. P., Rogers H. W., Corbett J. A., Schreiber R. D., McDaniel M. L., Unanue E. R. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol. 1993 Feb 1;150(3):888–895. [PubMed] [Google Scholar]
  14. Benjamin N., O'Driscoll F., Dougall H., Duncan C., Smith L., Golden M., McKenzie H. Stomach NO synthesis. Nature. 1994 Apr 7;368(6471):502–502. doi: 10.1038/368502a0. [DOI] [PubMed] [Google Scholar]
  15. Beno D. W., Stöver A. G., Mathews H. L. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol. 1995 May 15;154(10):5273–5281. [PubMed] [Google Scholar]
  16. Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun. 1986 Feb;51(2):668–674. doi: 10.1128/iai.51.2.668-674.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Blasi E., Bartoli A., Barluzzi R., Mazzolla R., Bistoni F. Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicans. J Neuroimmunol. 1994 Jul;52(2):205–213. doi: 10.1016/0165-5728(94)90114-7. [DOI] [PubMed] [Google Scholar]
  18. Blasi E., Farinelli S., Varesio L., Bistoni F. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect Immun. 1990 Apr;58(4):1073–1077. doi: 10.1128/iai.58.4.1073-1077.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Blasi E., Pitzurra L., Puliti M., Chimienti A. R., Mazzolla R., Barluzzi R., Bistoni F. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect Immun. 1995 May;63(5):1806–1809. doi: 10.1128/iai.63.5.1806-1809.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Blasi E., Pitzurra L., Puliti M., Lanfrancone L., Bistoni F. Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans. Infect Immun. 1992 Mar;60(3):832–837. doi: 10.1128/iai.60.3.832-837.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Blasi E., Puliti M., Pitzurra L., Bartoli A., Bistoni F. Heterogeneous secretory response of phagocytes from different anatomical districts to the dimorphic fungus Candida albicans. Cell Immunol. 1994 Jan;153(1):239–247. doi: 10.1006/cimm.1994.1021. [DOI] [PubMed] [Google Scholar]
  22. Bortolussi R., Faulkner G., Lee S. H., Ozere R. Phagocytosis of Candida albicans in chronic mucocutaneous candidiasis. Pediatr Res. 1981 Sep;15(9):1287–1292. doi: 10.1203/00006450-198109000-00012. [DOI] [PubMed] [Google Scholar]
  23. Brummer E., Hanson L. H., Restrepo A., Stevens D. A. In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. J Immunol. 1988 Apr 15;140(8):2786–2789. [PubMed] [Google Scholar]
  24. Brummer E., Morrison C. J., Stevens D. A. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun. 1985 Sep;49(3):724–730. doi: 10.1128/iai.49.3.724-730.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Brummer E., Stevens D. A. Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clin Exp Immunol. 1987 Dec;70(3):520–528. [PMC free article] [PubMed] [Google Scholar]
  26. Brummer E., Stevens D. A. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon. J Med Microbiol. 1989 Mar;28(3):173–181. doi: 10.1099/00222615-28-3-173. [DOI] [PubMed] [Google Scholar]
  27. Busolo F., Conventi L., Grigolon M., Bassi P., Milani C., Meneghini A., Pagano F. Effects of bacillus of Calmette-Guerin, Candida albicans and human recombinant interferon-gamma on RNA metabolism and on in vitro release of tumor necrosis factor-alpha by human monocytes/macrophages. New Microbiol. 1993 Jul;16(3):259–266. [PubMed] [Google Scholar]
  28. Byrd T. F., Horwitz M. A. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J Clin Invest. 1993 Mar;91(3):969–976. doi: 10.1172/JCI116318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Calderone R. A., Braun P. C. Adherence and receptor relationships of Candida albicans. Microbiol Rev. 1991 Mar;55(1):1–20. doi: 10.1128/mr.55.1.1-20.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Calderone R., Sturtevant J. Macrophage interactions with Candida. Immunol Ser. 1994;60:505–515. [PubMed] [Google Scholar]
  31. Cantorna M. T., Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun. 1990 Apr;58(4):1093–1100. doi: 10.1128/iai.58.4.1093-1100.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Cantorna M. T., Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun. 1991 Jul;59(7):2447–2455. doi: 10.1128/iai.59.7.2447-2455.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Cantorna M., Mook D., Balish E. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect Immun. 1990 Nov;58(11):3813–3815. doi: 10.1128/iai.58.11.3813-3815.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Casadevall A. Antibody immunity and invasive fungal infections. Infect Immun. 1995 Nov;63(11):4211–4218. doi: 10.1128/iai.63.11.4211-4218.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Castro M., Bjoraker J. A., Rohrbach M. S., Limper A. H. Candida albicans induces the release of inflammatory mediators from human peripheral blood monocytes. Inflammation. 1996 Feb;20(1):107–122. doi: 10.1007/BF01487749. [DOI] [PubMed] [Google Scholar]
  36. Castro M., Ralston N. V., Morgenthaler T. I., Rohrbach M. S., Limper A. H. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect Immun. 1994 Aug;62(8):3138–3145. doi: 10.1128/iai.62.8.3138-3145.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Cenci E., Romani L., Mencacci A., Spaccapelo R., Schiaffella E., Puccetti P., Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol. 1993 May;23(5):1034–1038. doi: 10.1002/eji.1830230508. [DOI] [PubMed] [Google Scholar]
  38. Cenci E., Romani L., Vecchiarelli A., Puccetti P., Bistoni F. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect Immun. 1989 Nov;57(11):3581–3587. doi: 10.1128/iai.57.11.3581-3587.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Chakir J., Côté L., Coulombe C., Deslauriers N. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol Immunol. 1994 Apr;9(2):88–94. doi: 10.1111/j.1399-302x.1994.tb00040.x. [DOI] [PubMed] [Google Scholar]
  40. Chan J., Xing Y., Magliozzo R. S., Bloom B. R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992 Apr 1;175(4):1111–1122. doi: 10.1084/jem.175.4.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Chaturvedi S., Frame P., Newman S. L. Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J Infect Dis. 1995 Feb;171(2):320–327. doi: 10.1093/infdis/171.2.320. [DOI] [PubMed] [Google Scholar]
  42. Clift R. A. Candidiasis in the transplant patient. Am J Med. 1984 Oct 30;77(4D):34–38. [PubMed] [Google Scholar]
  43. Cline M. J., Lehrer R. I. Phagocytosis by human monocytes. Blood. 1968 Sep;32(3):423–435. [PubMed] [Google Scholar]
  44. Coker L. A., 3rd, Mercadal C. M., Rouse B. T., Moore R. N. Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. J Leukoc Biol. 1992 Mar;51(3):305–306. doi: 10.1002/jlb.51.3.305. [DOI] [PubMed] [Google Scholar]
  45. Cole G. T., Halawa A. A., Anaissie E. J. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis. 1996 May;22 (Suppl 2):S73–S88. doi: 10.1093/clinids/22.supplement_2.s73. [DOI] [PubMed] [Google Scholar]
  46. Cole G. T., Saha K., Seshan K. R., Lynn K. T., Franco M., Wong P. K. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect Immun. 1992 Oct;60(10):4168–4178. doi: 10.1128/iai.60.10.4168-4178.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Costa-Casnellie M. R., Segel G. B., Lichtman M. A. Concanavalin A and phorbol ester cause opposite subcellular redistribution of protein kinase C. Biochem Biophys Res Commun. 1985 Dec 31;133(3):1139–1144. doi: 10.1016/0006-291x(85)91255-0. [DOI] [PubMed] [Google Scholar]
  48. Crowe S. M., Vardaxis N. J., Kent S. J., Maerz A. L., Hewish M. J., McGrath M. S., Mills J. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol. 1994 Sep;56(3):318–327. doi: 10.1002/jlb.56.3.318. [DOI] [PubMed] [Google Scholar]
  49. Cuff C. F., Rogers C. M., Lamb B. J., Rogers T. J. Induction of suppressor cells in vitro by Candida albicans. Cell Immunol. 1986 Jun;100(1):47–56. doi: 10.1016/0008-8749(86)90005-5. [DOI] [PubMed] [Google Scholar]
  50. Cuff C. F., Taub D. D., Rogers T. J. The induction of T-suppressor cells with a soluble extract of Candida albicans. Cell Immunol. 1989 Aug;122(1):71–82. doi: 10.1016/0008-8749(89)90149-4. [DOI] [PubMed] [Google Scholar]
  51. Curnutte J. T. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin Immunol Immunopathol. 1993 Jun;67(3 Pt 2):S2–15. doi: 10.1006/clin.1993.1078. [DOI] [PubMed] [Google Scholar]
  52. Cutler J. E. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J Reticuloendothel Soc. 1976 Feb;19(2):121–124. [PubMed] [Google Scholar]
  53. Cutler J. E., Poor A. H. Effect of mouse phagocytes on Candida albicans in in vivo chambers. Infect Immun. 1981 Mar;31(3):1110–1116. doi: 10.1128/iai.31.3.1110-1116.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Czop J. K., Austen K. F. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis. Proc Natl Acad Sci U S A. 1985 May;82(9):2751–2755. doi: 10.1073/pnas.82.9.2751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Czop J. K., Austen K. F. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J Immunol. 1985 Nov;135(5):3388–3393. [PubMed] [Google Scholar]
  56. Dale D. C., Guerry D., 4th, Wewerka J. R., Bull J. M., Chusid M. J. Chronic neutropenia. Medicine (Baltimore) 1979 Mar;58(2):128–144. doi: 10.1097/00005792-197903000-00002. [DOI] [PubMed] [Google Scholar]
  57. Danley D. L., Polakoff J. Rapid killing of monocytes in vitro by Candida albicans yeast cells. Infect Immun. 1986 Jan;51(1):307–313. doi: 10.1128/iai.51.1.307-313.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Daum T., Rohrbach M. S. Zymosan induces selective release of arachidonic acid from rabbit alveolar macrophages via stimulation of a beta-glucan receptor. FEBS Lett. 1992 Sep 7;309(2):119–122. doi: 10.1016/0014-5793(92)81077-y. [DOI] [PubMed] [Google Scholar]
  59. De Groote M. A., Testerman T., Xu Y., Stauffer G., Fang F. C. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science. 1996 Apr 19;272(5260):414–417. doi: 10.1126/science.272.5260.414. [DOI] [PubMed] [Google Scholar]
  60. Decker T., Baccarini M., Lohmann-Matthes M. L. Liver-associated macrophage precursors as natural cytotoxic effectors against Candida albicans and Yac-1 cells. Eur J Immunol. 1986 Jun;16(6):693–699. doi: 10.1002/eji.1830160618. [DOI] [PubMed] [Google Scholar]
  61. Decker T., Lohmann-Matthes M. L., Baccarini M. Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans. Infect Immun. 1986 Nov;54(2):477–486. doi: 10.1128/iai.54.2.477-486.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 1994 May;55(5):682–684. doi: 10.1002/jlb.55.5.682. [DOI] [PubMed] [Google Scholar]
  63. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol. 1991 Apr;49(4):380–387. doi: 10.1002/jlb.49.4.380. [DOI] [PubMed] [Google Scholar]
  64. Denlinger L. C., Fisette P. L., Garis K. A., Kwon G., Vazquez-Torres A., Simon A. D., Nguyen B., Proctor R. A., Bertics P. J., Corbett J. A. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem. 1996 Jan 5;271(1):337–342. doi: 10.1074/jbc.271.1.337. [DOI] [PubMed] [Google Scholar]
  65. Diamond R. D., Clark R. A., Haudenschild C. C. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J Clin Invest. 1980 Nov;66(5):908–917. doi: 10.1172/JCI109958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Diamond R. D., Haudenschild C. C. Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro. J Clin Invest. 1981 Jan;67(1):173–182. doi: 10.1172/JCI110010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Diamond R. D., Lyman C. A., Wysong D. R. Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J Clin Invest. 1991 Feb;87(2):711–720. doi: 10.1172/JCI115050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Djeu J. Y., Blanchard D. K., Richards A. L., Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol. 1988 Dec 1;141(11):4047–4052. [PubMed] [Google Scholar]
  69. Duncan C., Dougall H., Johnston P., Green S., Brogan R., Leifert C., Smith L., Golden M., Benjamin N. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med. 1995 Jun;1(6):546–551. doi: 10.1038/nm0695-546. [DOI] [PubMed] [Google Scholar]
  70. Elstad M. R., Parker C. J., Cowley F. S., Wilcox L. A., McIntyre T. M., Prescott S. M., Zimmerman G. A. CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. J Immunol. 1994 Jan 1;152(1):220–230. [PubMed] [Google Scholar]
  71. Enelow R. I., Sullivan G. W., Carper H. T., Mandell G. L. Cytokine-induced human multinucleated giant cells have enhanced candidacidal activity and oxidative capacity compared with macrophages. J Infect Dis. 1992 Sep;166(3):664–668. doi: 10.1093/infdis/166.3.664. [DOI] [PubMed] [Google Scholar]
  72. Evron R. In vitro phagocytosis of Candida albicans by peritoneal mouse macrophages. Infect Immun. 1980 Jun;28(3):963–971. doi: 10.1128/iai.28.3.963-971.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Felipe I., Bochio E. E., Martins N. B., Pacheco C. Inhibition of macrophage phagocytosis of Escherichia coli by mannose and mannan. Braz J Med Biol Res. 1991;24(9):919–924. [PubMed] [Google Scholar]
  74. Fidel P. L., Jr, Lynch M. E., Conaway D. H., Tait L., Sobel J. D. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun. 1995 Feb;63(2):547–553. doi: 10.1128/iai.63.2.547-553.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Fidel P. L., Jr, Wolf N. A., KuKuruga M. A. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun. 1996 Sep;64(9):3793–3799. doi: 10.1128/iai.64.9.3793-3799.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Flesch I. E., Kaufmann S. H. Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages. Infect Immun. 1988 Jun;56(6):1464–1469. doi: 10.1128/iai.56.6.1464-1469.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Fradin C., Jouault T., Mallet A., Mallet J. M., Camus D., Sinaÿ P., Poulain D. Beta-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J Leukoc Biol. 1996 Jul;60(1):81–87. doi: 10.1002/jlb.60.1.81. [DOI] [PubMed] [Google Scholar]
  78. Fromtling R. A., Shadomy H. J. An overview of macrophage-fungal interactions. Mycopathologia. 1986 Feb;93(2):77–93. doi: 10.1007/BF00437738. [DOI] [PubMed] [Google Scholar]
  79. Fujita T., Taira S., Kodama N., Matsushita M., Fujita T. Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway. Jpn J Cancer Res. 1995 Feb;86(2):187–192. doi: 10.1111/j.1349-7006.1995.tb03038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Ganser A., Ottmann O. G., Erdmann H., Schulz G., Hoelzer D. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Ann Intern Med. 1989 Dec 1;111(11):887–892. doi: 10.7326/0003-4819-111-11-887. [DOI] [PubMed] [Google Scholar]
  81. Garcha U. K., Brummer E., Stevens D. A. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species. J Infect Dis. 1995 Dec;172(6):1620–1623. doi: 10.1093/infdis/172.6.1620. [DOI] [PubMed] [Google Scholar]
  82. Garner R. E., Childress A. M., Human L. G., Domer J. E. Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells. Infect Immun. 1990 Aug;58(8):2613–2620. doi: 10.1128/iai.58.8.2613-2620.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Garner R. E., Kuruganti U., Czarniecki C. W., Chiu H. H., Domer J. E. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infect Immun. 1989 Jun;57(6):1800–1808. doi: 10.1128/iai.57.6.1800-1808.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Garner R. E., Rubanowice K., Sawyer R. T., Hudson J. A. Secretion of TNF-alpha by alveolar macrophages in response to Candida albicans mannan. J Leukoc Biol. 1994 Feb;55(2):161–168. doi: 10.1002/jlb.55.2.161. [DOI] [PubMed] [Google Scholar]
  85. Goldman R., Ferber E., Meller R., Zor U. A role for reactive oxygen species in zymosan and beta-glucan induced protein tyrosine phosphorylation and phospholipase A2 activation in murine macrophages. Biochim Biophys Acta. 1994 Jun 30;1222(2):265–276. doi: 10.1016/0167-4889(94)90178-3. [DOI] [PubMed] [Google Scholar]
  86. Greenfield R. A., Abrams V. L., Crawford D. L., Kuhls T. L. Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency. Infect Immun. 1993 Jun;61(6):2520–2525. doi: 10.1128/iai.61.6.2520-2525.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Greenfield R. A. Host defense system interactions with Candida. J Med Vet Mycol. 1992;30(2):89–104. [PubMed] [Google Scholar]
  88. Han Y., Cutler J. E. Antibody response that protects against disseminated candidiasis. Infect Immun. 1995 Jul;63(7):2714–2719. doi: 10.1128/iai.63.7.2714-2719.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Han Y., Kelm S., Riesselman M. H., Crocker P. R., Cutler J. E. Mouse sialoadhesin is not responsible for Candida albicans yeast cell binding to splenic marginal zone macrophages. Infect Immun. 1994 May;62(5):2115–2118. doi: 10.1128/iai.62.5.2115-2118.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Hashimoto T. In vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium. Infect Immun. 1991 Oct;59(10):3555–3561. doi: 10.1128/iai.59.10.3555-3561.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Hassett D. J., Cohen M. S. Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J. 1989 Dec;3(14):2574–2582. doi: 10.1096/fasebj.3.14.2556311. [DOI] [PubMed] [Google Scholar]
  92. Hill J. O. CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J Exp Med. 1992 Jun 1;175(6):1685–1695. doi: 10.1084/jem.175.6.1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Hoffman O. A., Olson E. J., Limper A. H. Fungal beta-glucans modulate macrophage release of tumor necrosis factor-alpha in response to bacterial lipopolysaccharide. Immunol Lett. 1993 Jul;37(1):19–25. doi: 10.1016/0165-2478(93)90127-n. [DOI] [PubMed] [Google Scholar]
  94. Hostetter M. K. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990 Mar;39(3):271–275. doi: 10.2337/diab.39.3.271. [DOI] [PubMed] [Google Scholar]
  95. Huffnagle G. B., Yates J. L., Lipscomb M. F. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun. 1991 Apr;59(4):1423–1433. doi: 10.1128/iai.59.4.1423-1433.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Hume D. A., Denkins Y. The deleterious effect of macrophage colony-stimulating factor (CSF-1) on the pathology of experimental candidiasis in mice. Lymphokine Cytokine Res. 1992 Apr;11(2):95–98. [PubMed] [Google Scholar]
  97. Hurley R., Stanley V. C. Cytopathic effects of pathogenic and non-pathogenic species of Candida on cultured mouse epithelial cells: relation to the growth rate and morphology of the fungi. J Med Microbiol. 1969 Feb;2(1):63–74. doi: 10.1099/00222615-2-1-63. [DOI] [PubMed] [Google Scholar]
  98. Høgåsen A. K., Abrahamsen T. G. Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor. Infect Immun. 1993 May;61(5):1779–1785. doi: 10.1128/iai.61.5.1779-1785.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Janusz M. J., Austen K. F., Czop J. K. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte beta-glucan receptors. Immunology. 1988 Oct;65(2):181–185. [PMC free article] [PubMed] [Google Scholar]
  100. Jensen J., Vazquez-Torres A., Balish E. Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis. Infect Immun. 1992 Nov;60(11):4549–4557. doi: 10.1128/iai.60.11.4549-4557.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Jensen J., Warner T., Balish E. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J Infect Dis. 1993 Apr;167(4):912–919. doi: 10.1093/infdis/167.4.912. [DOI] [PubMed] [Google Scholar]
  102. Jensen J., Warner T., Balish E. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J Infect Dis. 1994 Oct;170(4):900–905. doi: 10.1093/infdis/170.4.900. [DOI] [PubMed] [Google Scholar]
  103. Jensen J., Warner T., Johnson C., Balish E. Oral immunization of mice against candidiasis. J Infect Dis. 1996 Jul;174(1):133–140. doi: 10.1093/infdis/174.1.133. [DOI] [PubMed] [Google Scholar]
  104. Jiang G. Z., Sugiyama T., Kato Y., Koide N., Yokochi T. Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect Immun. 1995 Jul;63(7):2537–2540. doi: 10.1128/iai.63.7.2537-2540.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Johnston R. B., Newman S. L. Chronic granulomatous disease. Pediatr Clin North Am. 1977 May;24(2):365–376. doi: 10.1016/s0031-3955(16)33424-1. [DOI] [PubMed] [Google Scholar]
  106. Jones-Carson J., Vazquez-Torres A., Balish E. Defective killing of Candida albicans hyphae by neutrophils from beige mice. J Infect Dis. 1995 Jun;171(6):1664–1667. doi: 10.1093/infdis/171.6.1664. [DOI] [PubMed] [Google Scholar]
  107. Jones-Carson J., Vazquez-Torres A., van der Heyde H. C., Warner T., Wagner R. D., Balish E. Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat Med. 1995 Jun;1(6):552–557. doi: 10.1038/nm0695-552. [DOI] [PubMed] [Google Scholar]
  108. Jouault T., Bernigaud A., Lepage G., Trinel P. A., Poulain D. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages. Immunology. 1994 Oct;83(2):268–273. [PMC free article] [PubMed] [Google Scholar]
  109. Jouault T., Lepage G., Bernigaud A., Trinel P. A., Fradin C., Wieruszeski J. M., Strecker G., Poulain D. Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect Immun. 1995 Jun;63(6):2378–2381. doi: 10.1128/iai.63.6.2378-2381.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Kagaya K., Fukazawa Y. Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans. Microbiol Immunol. 1981;25(8):807–818. doi: 10.1111/j.1348-0421.1981.tb00084.x. [DOI] [PubMed] [Google Scholar]
  111. Kaplan S. S., Lancaster J. R., Jr, Basford R. E., Simmons R. L. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun. 1996 Jan;64(1):69–76. doi: 10.1128/iai.64.1.69-76.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Karbassi A., Becker J. M., Foster J. S., Moore R. N. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J Immunol. 1987 Jul 15;139(2):417–421. [PubMed] [Google Scholar]
  113. Kataoka M., Tavassoli M. Development of specific surface receptors recognizing mannose-terminal glycoconjugates in cultured monocytes: a possible early marker for differentiation of monocyte into macrophage. Exp Hematol. 1985 Jan;13(1):44–50. [PubMed] [Google Scholar]
  114. Kennedy M. J., Rogers A. L., Hanselmen L. R., Soll D. R., Yancey R. J., Jr Variation in adhesion and cell surface hydrophobicity in Candida albicans white and opaque phenotypes. Mycopathologia. 1988 Jun;102(3):149–156. doi: 10.1007/BF00437397. [DOI] [PubMed] [Google Scholar]
  115. Kennedy M. T., Bates P. J., Wheatley C. L., Rohrbach M. S. Discrete pathways for arachidonic acid release from tannin versus beta-glucan-stimulated rabbit alveolar macrophages. J Leukoc Biol. 1995 Aug;58(2):241–248. doi: 10.1002/jlb.58.2.241. [DOI] [PubMed] [Google Scholar]
  116. Khwaja A., Johnson B., Addison I. E., Yong K., Ruthven K., Abramson S., Linch D. C. In vivo effects of macrophage colony-stimulating factor on human monocyte function. Br J Haematol. 1991 Jan;77(1):25–31. doi: 10.1111/j.1365-2141.1991.tb07943.x. [DOI] [PubMed] [Google Scholar]
  117. Kitz D. J., Stahl P. D., Little J. R. The effect of a mannose binding protein on macrophage interactions with Candida albicans. Cell Mol Biol. 1992 Jul;38(4):407–412. [PubMed] [Google Scholar]
  118. Klein R. S., Harris C. A., Small C. B., Moll B., Lesser M., Friedland G. H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 9;311(6):354–358. doi: 10.1056/NEJM198408093110602. [DOI] [PubMed] [Google Scholar]
  119. Kolotila M. P., Rogers A. L., Beneke E. S., Smith C. W. The effects of soluble Saccharomyces cerevisiae mannan on the phagocytosis of Candida albicans by mouse peritoneal macrophages in vitro. J Med Vet Mycol. 1987 Apr;25(2):85–96. [PubMed] [Google Scholar]
  120. Konopski Z., Seljelid R., Eskeland T. IFN-gamma inhibits internalization of soluble aminated beta-1,3-D-glucan by macrophages and thereby down-regulates the glucan induced release of TNF-alpha and IL-1 beta. Scand J Immunol. 1994 Jul;40(1):57–63. doi: 10.1111/j.1365-3083.1994.tb03433.x. [DOI] [PubMed] [Google Scholar]
  121. Kullberg B. J., van 't Wout J. W., van Furth R. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun. 1990 Oct;58(10):3319–3324. doi: 10.1128/iai.58.10.3319-3324.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Kwon-Chung K. J., Lehman D., Good C., Magee P. T. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun. 1985 Sep;49(3):571–575. doi: 10.1128/iai.49.3.571-575.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Laszlo D. J., Henson P. M., Remigio L. K., Weinstein L., Sable C., Noble P. W., Riches D. W. Development of functional diversity in mouse macrophages. Mutual exclusion of two phenotypic states. Am J Pathol. 1993 Aug;143(2):587–597. [PMC free article] [PubMed] [Google Scholar]
  124. Leenen P. J., Canono B. P., Drevets D. A., Voerman J. S., Campbell P. A. TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J Immunol. 1994 Dec 1;153(11):5141–5147. [PubMed] [Google Scholar]
  125. Lefkowitz S. S., Gelderman M. P., Lefkowitz D. L., Moguilevsky N., Bollen A. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J Infect Dis. 1996 May;173(5):1202–1207. doi: 10.1093/infdis/173.5.1202. [DOI] [PubMed] [Google Scholar]
  126. Lehrer R. I., Cline M. J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest. 1969 Aug;48(8):1478–1488. doi: 10.1172/JCI106114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Lehrer R. I., Ferrari L. G., Patterson-Delafield J., Sorrell T. Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans. Infect Immun. 1980 Jun;28(3):1001–1008. doi: 10.1128/iai.28.3.1001-1008.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Lehrer R. I. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest. 1975 Feb;55(2):338–346. doi: 10.1172/JCI107937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Leijh P. C., van den Barselaar M. T., van Furth R. Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun. 1977 Aug;17(2):313–318. doi: 10.1128/iai.17.2.313-318.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Levitz S. M., Diamond R. D. Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system. Infect Immun. 1984 Mar;43(3):1100–1102. doi: 10.1128/iai.43.3.1100-1102.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Levitz S. M., Mathews H. L., Murphy J. W. Direct antimicrobial activity of T cells. Immunol Today. 1995 Aug;16(8):387–391. doi: 10.1016/0167-5699(95)80007-7. [DOI] [PubMed] [Google Scholar]
  132. Levy R., Latzer S., Sachs J., Insler V., Alkan M. Host defense during pregnancy: monocyte adherence and killing. Isr J Med Sci. 1990 Jul;26(7):361–366. [PubMed] [Google Scholar]
  133. Lew D. B., Leslie C. C., Henson P. M., Riches D. W. Role of endogenously derived leukotrienes in the regulation of lysosomal enzyme expression in macrophages exposed to beta 1,3-glucan. J Leukoc Biol. 1991 Mar;49(3):266–276. doi: 10.1002/jlb.49.3.266. [DOI] [PubMed] [Google Scholar]
  134. Li R. K., Cutler J. E. Chemical definition of an epitope/adhesin molecule on Candida albicans. J Biol Chem. 1993 Aug 25;268(24):18293–18299. [PubMed] [Google Scholar]
  135. Limper A. H., Standing J. E. Vitronectin interacts with Candida albicans and augments organism attachment to the NR8383 macrophage cell line. Immunol Lett. 1994 Oct;42(3):139–144. doi: 10.1016/0165-2478(94)90077-9. [DOI] [PubMed] [Google Scholar]
  136. Lipscomb M. F., Huffnagle G. B., Lovchik J. A., Lyons C. R., Pollard A. M., Yates J. L. The role of T lymphocytes in pulmonary microbial defense mechanisms. Arch Pathol Lab Med. 1993 Dec;117(12):1225–1232. [PubMed] [Google Scholar]
  137. Louie A., Baltch A. L., Franke M. A., Smith R. P., Gordon M. A. Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone. J Antimicrob Chemother. 1994 Dec;34(6):975–987. doi: 10.1093/jac/34.6.975. [DOI] [PubMed] [Google Scholar]
  138. Lyall E. G., Lucas G. F., Eden O. B. Autoimmune neutropenia of infancy. J Clin Pathol. 1992 May;45(5):431–434. doi: 10.1136/jcp.45.5.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Macdonald F., Odds F. C. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J Med Microbiol. 1980 Aug;13(3):423–435. doi: 10.1099/00222615-13-3-423. [DOI] [PubMed] [Google Scholar]
  140. Maiti P. K., Kumar R., Mohapatra L. N. Candidacidal activity of mouse macrophages in vitro. Infect Immun. 1980 Aug;29(2):477–482. doi: 10.1128/iai.29.2.477-482.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Maksymiuk A. W., Thongprasert S., Hopfer R., Luna M., Fainstein V., Bodey G. P. Systemic candidiasis in cancer patients. Am J Med. 1984 Oct 30;77(4D):20–27. [PubMed] [Google Scholar]
  142. Martin E., Stüben A., Görz A., Weller U., Bhakdi S. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob Agents Chemother. 1994 Jan;38(1):13–22. doi: 10.1128/aac.38.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Maródi L., Forehand J. R., Johnston R. B., Jr Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol. 1991 Apr 15;146(8):2790–2794. [PubMed] [Google Scholar]
  144. Maródi L., Johnston R. B., Jr Enhancement of macrophage candidacidal activity by interferon-gamma. Immunodeficiency. 1993;4(1-4):181–185. [PubMed] [Google Scholar]
  145. Maródi L., Korchak H. M., Johnston R. B., Jr Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol. 1991 Apr 15;146(8):2783–2789. [PubMed] [Google Scholar]
  146. Maródi L., Káposzta R., Campbell D. E., Polin R. A., Csongor J., Johnston R. B., Jr Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol. 1994 Dec 15;153(12):5643–5649. [PubMed] [Google Scholar]
  147. Maródi L., Schreiber S., Anderson D. C., MacDermott R. P., Korchak H. M., Johnston R. B., Jr Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest. 1993 Jun;91(6):2596–2601. doi: 10.1172/JCI116498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med. 1992 Dec 1;176(6):1497–1502. doi: 10.1084/jem.176.6.1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Matthews R. C., Burnie J. P., Howat D., Rowland T., Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology. 1991 Sep;74(1):20–24. [PMC free article] [PubMed] [Google Scholar]
  150. Matthews R., Burnie J. The role of hsp90 in fungal infection. Immunol Today. 1992 Sep;13(9):345–348. doi: 10.1016/0167-5699(92)90169-8. [DOI] [PubMed] [Google Scholar]
  151. Meister H., Heymer B., Schäfer H., Haferkamp O. Role of Candida albicans in granulomatous tissue reactions. II. In vivo degradation of C. albicans in hepatic macrophages of mice. J Infect Dis. 1977 Feb;135(2):235–242. doi: 10.1093/infdis/135.2.235. [DOI] [PubMed] [Google Scholar]
  152. Merendino R. A., Arena A., Delfino D., Zummo S., Mesiti M., Chillemi S., Bonina L. Generation of superoxide anion and candidacidal activity by lipopolysaccharide-treated macrophages from patients affected by neoplasia. J Chemother. 1992 Feb;4(1):35–40. doi: 10.1080/1120009x.1992.11739136. [DOI] [PubMed] [Google Scholar]
  153. Miller R. A., Britigan B. E. Role of oxidants in microbial pathophysiology. Clin Microbiol Rev. 1997 Jan;10(1):1–18. doi: 10.1128/cmr.10.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Minami A., Fujimoto K., Ozaki Y., Nakamura S. Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha. Infect Immun. 1988 Dec;56(12):3116–3120. doi: 10.1128/iai.56.12.3116-3120.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Miyazaki T., Kohno S., Mitsutake K., Maesaki S., Tanaka K., Ishikawa N., Hara K. Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol. 1995 Dec;33(12):3115–3118. doi: 10.1128/jcm.33.12.3115-3118.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Mohamed A. M. Ultrastructural aspects of chronic oral candidosis. J Oral Pathol. 1975 Oct-Nov;4(4):180–194. doi: 10.1111/j.1600-0714.1975.tb01741.x. [DOI] [PubMed] [Google Scholar]
  157. Mohr S., Stamler J. S., Brüne B. Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett. 1994 Jul 18;348(3):223–227. doi: 10.1016/0014-5793(94)00596-6. [DOI] [PubMed] [Google Scholar]
  158. Morrison R. P., Cutler J. E. In vitro studies of the interaction of murine phagocytic cells with Candida albicans. J Reticuloendothel Soc. 1981 Jan;29(1):23–34. [PubMed] [Google Scholar]
  159. Mouy R., Fischer A., Vilmer E., Seger R., Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989 Apr;114(4 Pt 1):555–560. doi: 10.1016/s0022-3476(89)80693-6. [DOI] [PubMed] [Google Scholar]
  160. Mukherjee S., Feldmesser M., Casadevall A. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J Infect Dis. 1996 May;173(5):1222–1231. doi: 10.1093/infdis/173.5.1222. [DOI] [PubMed] [Google Scholar]
  161. Murphy J. W. Immunity to fungi. Curr Opin Immunol. 1989;2(3):360–367. doi: 10.1016/0952-7915(89)90142-8. [DOI] [PubMed] [Google Scholar]
  162. Murray H. W., Cartelli D. M. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest. 1983 Jul;72(1):32–44. doi: 10.1172/JCI110972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Murray H. W., Rubin B. Y., Carriero S. M., Harris A. M., Jaffee E. A. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol. 1985 Mar;134(3):1982–1988. [PubMed] [Google Scholar]
  164. Narayanan R., Joyce W. A., Greenfield R. A. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun. 1991 Jun;59(6):2116–2119. doi: 10.1128/iai.59.6.2116-2119.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Naslund P. K., Miller W. C., Granger D. L. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infect Immun. 1995 Apr;63(4):1298–1304. doi: 10.1128/iai.63.4.1298-1304.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Nathan C. F., Hibbs J. B., Jr Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991 Feb;3(1):65–70. doi: 10.1016/0952-7915(91)90079-g. [DOI] [PubMed] [Google Scholar]
  167. Nathan C., Xie Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994 Sep 23;78(6):915–918. doi: 10.1016/0092-8674(94)90266-6. [DOI] [PubMed] [Google Scholar]
  168. Nelson R. D., Shibata N., Podzorski R. P., Herron M. J. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin Microbiol Rev. 1991 Jan;4(1):1–19. doi: 10.1128/cmr.4.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Nielsen H., Kharazmi A., Faber V. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand J Immunol. 1986 Sep;24(3):291–296. doi: 10.1111/j.1365-3083.1986.tb02096.x. [DOI] [PubMed] [Google Scholar]
  170. Noble P. W., Henson P. M., Lucas C., Mora-Worms M., Carré P. C., Riches D. W. Transforming growth factor-beta primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J Immunol. 1993 Jul 15;151(2):979–989. [PubMed] [Google Scholar]
  171. Nottet H. S., de Graaf L., de Vos N. M., Bakker L. J., van Strijp J. A., Visser M. R., Verhoef J. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J Infect Dis. 1993 Jul;168(1):84–91. doi: 10.1093/infdis/168.1.84. [DOI] [PubMed] [Google Scholar]
  172. Nunoshiba T., deRojas-Walker T., Wishnok J. S., Tannenbaum S. R., Demple B. Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9993–9997. doi: 10.1073/pnas.90.21.9993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Odds F. C. Morphogenesis in Candida albicans. Crit Rev Microbiol. 1985;12(1):45–93. doi: 10.3109/10408418509104425. [DOI] [PubMed] [Google Scholar]
  174. Odds F. C. Pathogenesis of Candida infections. J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S2–S5. doi: 10.1016/s0190-9622(08)81257-1. [DOI] [PubMed] [Google Scholar]
  175. Odds F. C., Webster C. E., Mayuranathan P., Simmons P. D. Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol. 1988;26(5):277–283. doi: 10.1080/02681218880000391. [DOI] [PubMed] [Google Scholar]
  176. Odell E. W., Segal A. W. Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils. J Med Microbiol. 1991 Mar;34(3):129–135. doi: 10.1099/00222615-34-3-129. [DOI] [PubMed] [Google Scholar]
  177. Oswald I. P., Wynn T. A., Sher A., James S. L. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8676–8680. doi: 10.1073/pnas.89.18.8676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Pacelli R., Wink D. A., Cook J. A., Krishna M. C., DeGraff W., Friedman N., Tsokos M., Samuni A., Mitchell J. B. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med. 1995 Nov 1;182(5):1469–1479. doi: 10.1084/jem.182.5.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Parry M. F., Root R. K., Metcalf J. A., Delaney K. K., Kaplow L. S., Richar W. J. Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med. 1981 Sep;95(3):293–301. doi: 10.7326/0003-4819-95-3-293. [DOI] [PubMed] [Google Scholar]
  180. Patterson-Delafield J., Martinez R. J., Lehrer R. I. Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun. 1980 Oct;30(1):180–192. doi: 10.1128/iai.30.1.180-192.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Patterson-Delafield J., Szklarek D., Martinez R. J., Lehrer R. I. Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes. Infect Immun. 1981 Feb;31(2):723–731. doi: 10.1128/iai.31.2.723-731.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Pearsall N. N., Adams B. L., Bunni R. Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol. 1978 Apr;120(4):1176–1180. [PubMed] [Google Scholar]
  183. Pecyk R. A., Fraser-Smith E. B., Matthews T. R. Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice. Infect Immun. 1989 Oct;57(10):3257–3258. doi: 10.1128/iai.57.10.3257-3258.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Peterson E. M., Calderone R. A. Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages. Infect Immun. 1978 Aug;21(2):506–513. doi: 10.1128/iai.21.2.506-513.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Peterson P. K., Gaziano E., Suh H. J., Devalon M., Peterson L., Keane W. F. Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun. 1985 Jul;49(1):212–218. doi: 10.1128/iai.49.1.212-218.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Poulain D., Hopwood V., Vernes A. Antigenic variability of Candida albicans. Crit Rev Microbiol. 1985;12(3):223–270. doi: 10.3109/10408418509104430. [DOI] [PubMed] [Google Scholar]
  187. Poutsiaka D. D., Mengozzi M., Vannier E., Sinha B., Dinarello C. A. Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production. Blood. 1993 Dec 15;82(12):3695–3700. [PubMed] [Google Scholar]
  188. Pryor W. A., Squadrito G. L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995 May;268(5 Pt 1):L699–L722. doi: 10.1152/ajplung.1995.268.5.L699. [DOI] [PubMed] [Google Scholar]
  189. Puccetti P., Romani L., Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 1995 Jun;3(6):237–240. doi: 10.1016/s0966-842x(00)88931-3. [DOI] [PubMed] [Google Scholar]
  190. Qian Q., Jutila M. A., Van Rooijen N., Cutler J. E. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol. 1994 May 15;152(10):5000–5008. [PubMed] [Google Scholar]
  191. Ray T. L., Hanson A., Ray L. F., Wuepper K. D. Purification of a mannan from Candida albicans which activates serum complement. J Invest Dermatol. 1979 Oct;73(4):269–274. doi: 10.1111/1523-1747.ep12531641. [DOI] [PubMed] [Google Scholar]
  192. Ray T. L., Wuepper K. D. Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J Invest Dermatol. 1976 Dec;67(6):700–703. doi: 10.1111/1523-1747.ep12598581. [DOI] [PubMed] [Google Scholar]
  193. Redmond H. P., Hofmann K., Shou J., Leon P., Kelly C. J., Daly J. M. Effects of laparotomy on systemic macrophage function. Surgery. 1992 Jun;111(6):647–655. [PubMed] [Google Scholar]
  194. Redmond H. P., Shou J., Gallagher H. J., Kelly C. J., Daly J. M. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. J Immunol. 1993 Apr 15;150(8 Pt 1):3427–3433. [PubMed] [Google Scholar]
  195. Rhoads J. L., Wright D. C., Redfield R. R., Burke D. S. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA. 1987 Jun 12;257(22):3105–3107. [PubMed] [Google Scholar]
  196. Riipi L., Carlson E. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase. Infect Immun. 1990 Sep;58(9):2750–2754. doi: 10.1128/iai.58.9.2750-2754.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Robinson J. E., Harvey B. A., Soothill J. F. Phagocytosis and killing of bacteria and yeast by human milk cells after opsonisation in aqueous phase of milk. Br Med J. 1978 Jun 3;1(6125):1443–1445. doi: 10.1136/bmj.1.6125.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Rogers T. J., Balish E. Immunity to Candida albicans. Microbiol Rev. 1980 Dec;44(4):660–682. doi: 10.1128/mr.44.4.660-682.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Rogers T. J., Balish E., Manning D. D. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc. 1976 Oct;20(4):291–298. [PubMed] [Google Scholar]
  200. Romani L., Howard D. H. Mechanisms of resistance to fungal infections. Curr Opin Immunol. 1995 Aug;7(4):517–523. doi: 10.1016/0952-7915(95)80097-2. [DOI] [PubMed] [Google Scholar]
  201. Romani L., Mencacci A., Cenci E., Mosci P., Vitellozzi G., Grohmann U., Puccetti P., Bistoni F. Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. J Infect Dis. 1992 Dec;166(6):1384–1392. doi: 10.1093/infdis/166.6.1384. [DOI] [PubMed] [Google Scholar]
  202. Romani L., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Puccetti P., Bistoni F. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol. 1993 Feb 1;150(3):925–931. [PubMed] [Google Scholar]
  203. Romani L., Mencacci A., Cenci E., Spaccapelo R., Schiaffella E., Tonnetti L., Puccetti P., Bistoni F. Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. Infect Immun. 1993 Sep;61(9):3769–3774. doi: 10.1128/iai.61.9.3769-3774.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Romani L., Mencacci A., Tonnetti L., Spaccapelo R., Cenci E., Wolf S., Puccetti P., Bistoni F. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur J Immunol. 1994 Apr;24(4):909–915. doi: 10.1002/eji.1830240419. [DOI] [PubMed] [Google Scholar]
  205. Romani L., Mocci S., Bietta C., Lanfaloni L., Puccetti P., Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun. 1991 Dec;59(12):4647–4654. doi: 10.1128/iai.59.12.4647-4654.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Rosati E., Scaringi L., Cornacchione P., Fettucciari K., Sabatini R., Rossi R., Marconi P. Cytokine response to inactivated Candida albicans in mice. Cell Immunol. 1995 May;162(2):256–264. doi: 10.1006/cimm.1995.1077. [DOI] [PubMed] [Google Scholar]
  207. Rosseau S., Seeger W., Pralle H., Lohmeyer J. Phagocytosis of viable Candida albicans by alveolar macrophages: flow cytometric quantification. Am J Physiol. 1994 Aug;267(2 Pt 1):L211–L217. doi: 10.1152/ajplung.1994.267.2.L211. [DOI] [PubMed] [Google Scholar]
  208. Rothermel C. D., Rubin B. Y., Jaffe E. A., Murray H. W. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages. J Immunol. 1986 Jul 15;137(2):689–692. [PubMed] [Google Scholar]
  209. Rutherford M. S., Witsell A., Schook L. B. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J Leukoc Biol. 1993 May;53(5):602–618. doi: 10.1002/jlb.53.5.602. [DOI] [PubMed] [Google Scholar]
  210. Sakurai T., Ohno N., Yadomae T. Effects of fungal beta-glucan and interferon-gamma on the secretory functions of murine alveolar macrophages. J Leukoc Biol. 1996 Jul;60(1):118–124. [PubMed] [Google Scholar]
  211. Saltarelli C. G., Gentile K. A., Mancuso S. C. Lethality of Candida strains as influenced by the host. Can J Microbiol. 1975 May;21(5):648–654. doi: 10.1139/m75-093. [DOI] [PubMed] [Google Scholar]
  212. Saral R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis. 1991 May-Jun;13(3):487–492. doi: 10.1093/clinids/13.3.487. [DOI] [PubMed] [Google Scholar]
  213. Sasada M., Johnston R. B., Jr Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med. 1980 Jul 1;152(1):85–98. doi: 10.1084/jem.152.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Sasada M., Kubo A., Nishimura T., Kakita T., Moriguchi T., Yamamoto K., Uchino H. Candidacidal activity of monocyte-derived human macrophages: relationship between Candida killing and oxygen radical generation by human macrophages. J Leukoc Biol. 1987 Apr;41(4):289–294. doi: 10.1002/jlb.41.4.289. [DOI] [PubMed] [Google Scholar]
  215. Sato T., Endo Y., Matsushita M., Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol. 1994 Apr;6(4):665–669. doi: 10.1093/intimm/6.4.665. [DOI] [PubMed] [Google Scholar]
  216. Sawyer R. T., Garner R. E., Hudson J. A. Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver. Infect Immun. 1992 Mar;60(3):1041–1046. doi: 10.1128/iai.60.3.1041-1046.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Sawyer R. T., Harmsen A. G. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans. Mycopathologia. 1989 Nov;108(2):95–105. doi: 10.1007/BF00436059. [DOI] [PubMed] [Google Scholar]
  218. Sawyer R. T., Horst M. N., Garner R. E., Hudson J., Jenkins P. R., Richardson A. L. Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model. Infect Immun. 1990 Sep;58(9):2869–2874. doi: 10.1128/iai.58.9.2869-2874.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Sawyer R. T., Moon R. J., Beneke E. S. Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers. Infect Immun. 1981 May;32(2):945–950. doi: 10.1128/iai.32.2.945-950.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Schuit K. E. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect Immun. 1979 Jun;24(3):932–938. doi: 10.1128/iai.24.3.932-938.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Scott P., James S., Sher A. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line. Eur J Immunol. 1985 Jun;15(6):553–558. doi: 10.1002/eji.1830150605. [DOI] [PubMed] [Google Scholar]
  222. Scully S. P., Segel G. B., Lichtman M. A. Calcium exchange and ionized cytoplasmic calcium in resting and activated human monocytes. J Clin Invest. 1984 Aug;74(2):589–599. doi: 10.1172/JCI111456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Shepherd V. L., Hoidal J. R. Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am J Respir Cell Mol Biol. 1990 Apr;2(4):335–340. doi: 10.1165/ajrcmb/2.4.335. [DOI] [PubMed] [Google Scholar]
  224. Smith P. D., Lamerson C. L., Banks S. M., Saini S. S., Wahl L. M., Calderone R. A., Wahl S. M. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis. 1990 May;161(5):999–1005. doi: 10.1093/infdis/161.5.999. [DOI] [PubMed] [Google Scholar]
  225. Sobel J. D., Muller G., Buckley H. R. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun. 1984 Jun;44(3):576–580. doi: 10.1128/iai.44.3.576-580.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Sohnle P. G., Frank M. M., Kirkpatrick C. H. Deposition of complement components in the cutaneous lesions of chronic mucocutaneous candidiasis. Clin Immunol Immunopathol. 1976 May;5(3):340–350. doi: 10.1016/0090-1229(76)90043-x. [DOI] [PubMed] [Google Scholar]
  227. Spaccapelo R., Romani L., Tonnetti L., Cenci E., Mencacci A., Del Sero G., Tognellini R., Reed S. G., Puccetti P., Bistoni F. TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J Immunol. 1995 Aug 1;155(3):1349–1360. [PubMed] [Google Scholar]
  228. Stahl P. D. The mannose receptor and other macrophage lectins. Curr Opin Immunol. 1992 Feb;4(1):49–52. doi: 10.1016/0952-7915(92)90123-v. [DOI] [PubMed] [Google Scholar]
  229. Stanley V. C., Hurley R. Growth of Candida species in cultures of mouse epithelial cells. J Pathol Bacteriol. 1967 Oct;94(2):301–315. doi: 10.1002/path.1700940207. [DOI] [PubMed] [Google Scholar]
  230. Stanley V. C., Hurley R. The growth of Candida species in cultures of mouse peritoneal macrophages. J Pathol. 1969 Feb;97(2):357–366. doi: 10.1002/path.1710970222. [DOI] [PubMed] [Google Scholar]
  231. Stein D. K., Malawista S. E., Van Blaricom G., Wysong D., Diamond R. D. Cytoplasts generate oxidants but require added neutrophil granule constituents for fungicidal activity against Candida albicans hyphae. J Infect Dis. 1995 Aug;172(2):511–520. doi: 10.1093/infdis/172.2.511. [DOI] [PubMed] [Google Scholar]
  232. Sullivan P. A., Yin C. Y., Molloy C., Templeton M. D., Shepherd M. G. An analysis of the metabolism and cell wall composition of Candida albicans during germ-tube formation. Can J Microbiol. 1983 Nov;29(11):1514–1525. doi: 10.1139/m83-233. [DOI] [PubMed] [Google Scholar]
  233. Super M., Ezekowitz R. A. The role of mannose-binding proteins in host defense. Infect Agents Dis. 1992 Aug;1(4):194–199. [PubMed] [Google Scholar]
  234. Syverson R. E., Buckley H., Gibian J., Ryan G. M., Jr Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol. 1979 Jul 15;134(6):624–627. doi: 10.1016/0002-9378(79)90641-0. [DOI] [PubMed] [Google Scholar]
  235. Tabona P., Mellor A., Summerfield J. A. Mannose binding protein is involved in first-line host defence: evidence from transgenic mice. Immunology. 1995 May;85(1):153–159. [PMC free article] [PubMed] [Google Scholar]
  236. Tachibana K., Chen G. J., Huang D. S., Scuderi P., Watson R. R. Production of tumor necrosis factor alpha by resident and activated murine macrophages. J Leukoc Biol. 1992 Mar;51(3):251–255. doi: 10.1002/jlb.51.3.251. [DOI] [PubMed] [Google Scholar]
  237. Tashjian J. H., Coulam C. B., Washington J. A., 2nd Vaginal flora in asymptomatic women. Mayo Clin Proc. 1976 Sep;51(9):557–561. [PubMed] [Google Scholar]
  238. Thompson H. L., Wilton J. M. Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leucocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions. Clin Exp Immunol. 1992 Feb;87(2):316–321. doi: 10.1111/j.1365-2249.1992.tb02994.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Tonnetti L., Spaccapelo R., Cenci E., Mencacci A., Puccetti P., Coffman R. L., Bistoni F., Romani L. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol. 1995 Jun;25(6):1559–1565. doi: 10.1002/eji.1830250614. [DOI] [PubMed] [Google Scholar]
  240. Van Der Meer J. W., Leijh P. C., Van Den Barselaar, Van Furth R. Functions of phagocytic cells in chronic mucocutaneous candidiasis. Br Med J. 1978 Jan 21;1(6106):147–148. doi: 10.1136/bmj.1.6106.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Van't Wout J. W., Van der Meer J. W., Barza M., Dinarello C. A. Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. Eur J Immunol. 1988 Jul;18(7):1143–1146. doi: 10.1002/eji.1830180728. [DOI] [PubMed] [Google Scholar]
  242. Vazquez-Torres A., Jones-Carson J., Balish E. Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice. J Infect Dis. 1994 Jul;170(1):180–188. doi: 10.1093/infdis/170.1.180. [DOI] [PubMed] [Google Scholar]
  243. Vazquez-Torres A., Jones-Carson J., Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect Immun. 1995 Mar;63(3):1142–1144. doi: 10.1128/iai.63.3.1142-1144.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Vazquez-Torres A., Jones-Carson J., Balish E. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect Immun. 1996 Aug;64(8):3127–3133. doi: 10.1128/iai.64.8.3127-3133.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Vazquez-Torres A., Jones-Carson J., Warner T., Balish E. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J Infect Dis. 1995 Jul;172(1):192–198. doi: 10.1093/infdis/172.1.192. [DOI] [PubMed] [Google Scholar]
  246. Vazquez N., Buckley H. R., Mosser D. M., Rogers T. J. Activation of murine resident peritoneal macrophages by a cell wall extract of Candida albicans. J Med Vet Mycol. 1995 Nov-Dec;33(6):385–393. doi: 10.1080/02681219580000751. [DOI] [PubMed] [Google Scholar]
  247. Vecchiarelli A., Bistoni F., Cenci E., Perito S., Cassone A. In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. Sabouraudia. 1985 Oct;23(5):377–387. doi: 10.1080/00362178585380541. [DOI] [PubMed] [Google Scholar]
  248. Vecchiarelli A., Dottorini M., Cociani C., Pietrella D., Todisco T., Bistoni F. Mechanism of intracellular candidacidal activity mediated by calcium ionophore in human alveolar macrophages. Am J Respir Cell Mol Biol. 1993 Jul;9(1):19–25. doi: 10.1165/ajrcmb/9.1.19. [DOI] [PubMed] [Google Scholar]
  249. Vecchiarelli A., Puliti M., Torosantucci A., Cassone A., Bistoni F. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell Immunol. 1991 Apr 15;134(1):65–76. doi: 10.1016/0008-8749(91)90331-5. [DOI] [PubMed] [Google Scholar]
  250. Vecchiarelli A., Todisco T., Puliti M., Dottorini M., Bistoni F. Modulation of anti-Candida activity of human alveolar macrophages by interferon-gamma or interleukin-1-alpha. Am J Respir Cell Mol Biol. 1989 Jul;1(1):49–55. doi: 10.1165/ajrcmb/1.1.49. [DOI] [PubMed] [Google Scholar]
  251. Wagner R. D., Vazquez-Torres A., Jones-Carson J., Warner T., Balish E. B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J Infect Dis. 1996 Sep;174(3):589–597. doi: 10.1093/infdis/174.3.589. [DOI] [PubMed] [Google Scholar]
  252. Wang M., Friedman H., Djeu J. Y. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol. 1989 Jul 15;143(2):671–677. [PubMed] [Google Scholar]
  253. Warr G. A. A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activity. Biochem Biophys Res Commun. 1980 Apr 14;93(3):737–745. doi: 10.1016/0006-291x(80)91139-0. [DOI] [PubMed] [Google Scholar]
  254. Watanabe K., Kagaya K., Yamada T., Fukazawa Y. Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon. Infect Immun. 1991 Feb;59(2):521–528. doi: 10.1128/iai.59.2.521-528.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Weinberg E. D. Iron depletion: a defense against intracellular infection and neoplasia. Life Sci. 1992;50(18):1289–1297. doi: 10.1016/0024-3205(92)90279-x. [DOI] [PubMed] [Google Scholar]
  256. Wey S. B., Mori M., Pfaller M. A., Woolson R. F., Wenzel R. P. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989 Oct;149(10):2349–2353. [PubMed] [Google Scholar]
  257. Wherry J. C., Schreiber R. D., Unanue E. R. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun. 1991 May;59(5):1709–1715. doi: 10.1128/iai.59.5.1709-1715.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. White T. C., Miyasaki S. H., Agabian N. Three distinct secreted aspartyl proteinases in Candida albicans. J Bacteriol. 1993 Oct;175(19):6126–6133. doi: 10.1128/jb.175.19.6126-6133.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Wildfeuer A., Laufen H., Haferkamp O. Wechselwirkungen von Fluconazol und phagozytierenden Zellen. Mycoses. 1991;34 (Suppl 1):53–57. [PubMed] [Google Scholar]
  260. Williams J. D., Czop J. K., Austen K. F. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol. 1984 Jun;132(6):3034–3040. [PubMed] [Google Scholar]
  261. Witkin S. S., Hirsch J., Ledger W. J. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol. 1986 Oct;155(4):790–795. doi: 10.1016/s0002-9378(86)80022-9. [DOI] [PubMed] [Google Scholar]
  262. Witkin S. S. Immunology of recurrent vaginitis. Am J Reprod Immunol Microbiol. 1987 Sep;15(1):34–37. doi: 10.1111/j.1600-0897.1987.tb00147.x. [DOI] [PubMed] [Google Scholar]
  263. Yamada Y., Saito H., Tomioka H., Jidoi J. Relationship between the susceptibility of various bacteria to active oxygen species and to intracellular killing by macrophages. J Gen Microbiol. 1987 Aug;133(8):2015–2021. doi: 10.1099/00221287-133-8-2015. [DOI] [PubMed] [Google Scholar]
  264. Yamaguchi H., Abe S., Tokuda Y. Immunomodulating activity of antifungal drugs. Ann N Y Acad Sci. 1993 Jun 23;685:447–457. doi: 10.1111/j.1749-6632.1993.tb35905.x. [DOI] [PubMed] [Google Scholar]
  265. Yamamura M., Valdimarsson H. Participation of C3 in intracellular killing of Candida albicans. Scand J Immunol. 1977;6(6-7):591–594. doi: 10.1111/j.1365-3083.1977.tb02137.x. [DOI] [PubMed] [Google Scholar]
  266. al-Doory Y. An immune factor in baboon anti-candida serum. Sabouraudia. 1970 May;8(1):41–47. doi: 10.1080/00362177085190621. [DOI] [PubMed] [Google Scholar]
  267. van 't Wout J. W., Linde I., Leijh P. C., van Furth R. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):736–741. doi: 10.1007/BF01975039. [DOI] [PubMed] [Google Scholar]
  268. van 't Wout J. W., Poell R., van Furth R. The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand J Immunol. 1992 Nov;36(5):713–719. doi: 10.1111/j.1365-3083.1992.tb03132.x. [DOI] [PubMed] [Google Scholar]

Articles from Microbiology and Molecular Biology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES